Aura Health Inc. (
CSE: BUZZ,
Forum) announced this week that it has closed the second tranche of its private placement subscription receipt offering of $5.82 million and executed a $3 million share exchange transaction with
FSD Pharma Inc.(CSE: HUGE,
OTCQB: FSDDF,
Forum).
For more information on this financing and exchange of shares, click
here.
As the Company builds its network of vertically-integrated cannabis assets, it recently bolstered its team with the
recent appointment of Alain Dobkin to its board of directors. He is a private equity investor with more than 20 years of investment and advisory experience, including 13 years with Citigroup Investment Bank in New York and Tel Aviv.
FULL DISCLOSURE: Aura Health Inc. and FSD Pharma Inc. are clients of Stockhouse Publishing.